HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stein, D. G. Articles by Bhuta, S. Search for Related Content PubMed PubMed Citation Articles by Stein, D. G. Articles by Bhuta, S.

The Journal of Thoracic and Cardiovascular Surgery, Vol 102, 657-665, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Cardiac preservation in patients undergoing transplantation. A clinical trial comparing University of Wisconsin solution and Stanford solution

DG Stein, DC Drinkwater Jr, H Laks, LC Permut, S Sangwan, HI Chait, JS Child and S Bhuta
Division of Cardiothoracic Surgery, University of California, Los Angeles Medical Center.

Recent laboratory investigations have shown significantly improved donor heart preservation and function when the University of Wisconsin solution (UW) is used for arrest and storage. These findings prompted us to compare UW to Stanford solution in a clinical trial. After giving informed consent, patients were blindly randomized to receive a heart arrested and stored in UW or a heart arrested in Stanford solution and stored in normal saline. Orthotopic transplants were performed in a routine manner. Fourteen patients with a mean age of 54 years were randomized to UW, and 15 patients with a mean age of 51 years were randomized to Stanford solution. Mean donor ages (UW 27 years, Stanford 24 years) and ischemic times (UW 150 minutes, Stanford 135 minutes) were similar. Several differences were observed intraoperatively. At end ischemia, mean adenosine triphosphate (UW 5.87 mmol/gm wet weight, Stanford 4.75 mmol/gm) and creatine phosphate (UW 9.26 mmol/gm, Stanford 4.75 mmol/gm) levels were higher in the UW hearts (p less than 0.05). Defibrillation requirements (UW 14% [2/14], Stanford 53% [8/15]) were significantly less in the UW group (p = 0.05). The number of patients requiring temporary intraoperative pacing also showed a significant difference with 7% (1/14) of UW patients versus 47% (7/15) of Stanford patients requiring pacing (p less than 0.05). Intraoperative requirement for inotropic support showed a trend in favor of the UW group. End-ischemic and postreperfusion histologic characteristics were similar between the two groups. No differences in hemodynamics or ejection fractions were noted postoperatively, but trends toward improved rhythm and decreased inotropic support were present in the UW group. Overall 6-month survival rates were similar (UW 86% [12/14], Stanford 93% [14/15]). No preservation-related deaths occurred. We conclude: (1) UW is a safe and effective preservation solution for human cardiac transplantation; (2) considering the improved end-ischemic adenosine triphosphate and creatine phosphate levels, decreased defibrillations, decreased intraoperative pacing, and trend toward decreased requirement for inotropic support in the UW group, UW appears to be superior to Stanford solution for donor heart preservation.

This article has been cited by other articles:

				D. Marelli, H. Laks, S. Bresson, A. Ardehali, J. Bresson, F. Esmailian, M. Plunkett, J. Moriguchi, and J. Kobashigawa Results after transplantation using donor hearts with preexisting coronary artery disease J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 821 - 825. [Abstract] [Full Text] [PDF]

				H. Laks, D. Marelli, G. C. Fonarow, M. A. Hamilton, A. Ardehali, J. D. Moriguchi, J. Bresson, D. Gjertson, and J. A. Kobashigawa Use of two recipient lists for adults requiring heart transplantation J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 49 - 59. [Abstract] [Full Text] [PDF]

				S. C. Stoica, D. K. Satchithananda, J. Dunning, and S. R. Large Two-decade analysis of cardiac storage for transplantation Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 792 - 798. [Abstract] [Full Text] [PDF]

				J. Redondo, M. E. Pacheco, A. M. Manso, M. Salaices, and J. Marin Cell volume and ionic transport systems after cold preservation of coronary endothelial cells Ann. Thorac. Surg., April 1, 2001; 71(4): 1290 - 1295. [Abstract] [Full Text] [PDF]

				G. B. Luciani, G. Faggian, G. Montalbano, G. Casali, A. Forni, B. Chiominto, and A. Mazzucco BLOOD VERSUS CRYSTALLOID CARDIOPLEGIA FOR MYOCARDIAL PROTECTION OF DONOR HEARTS DURING TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 787 - 795. [Abstract] [Full Text] [PDF]

				R. Ou, J. B. Gavin, D. S. Esmore, and F. L. Rosenfeldt Increased temperature reduces the protective effect of University of Wisconsin solution in the heart Ann. Thorac. Surg., November 1, 1999; 68(5): 1628 - 1634. [Abstract] [Full Text] [PDF]

				J. K. Kirklin and D. C. McGiffin Control of the inflammatory response in extended myocardial preservation of the donor heart Ann. Thorac. Surg., November 1, 1999; 68(5): 1978 - 1982. [Abstract] [Full Text] [PDF]

				M. S. Jahania, J. A. Sanchez, P. Narayan, R. D. Lasley, and R. M. Mentzer Jr Heart preservation for transplantation: principles and strategies Ann. Thorac. Surg., November 1, 1999; 68(5): 1983 - 1987. [Abstract] [Full Text] [PDF]

				R. S. Poston Jr, M. E. Billingham, J. Pollard, E. G. Hoyt, and R. C. Robbins Effects of Increased ICAM-1 on Reperfusion Injury and Chronic Graft Vascular Disease Ann. Thorac. Surg., October 1, 1997; 64(4): 1004 - 1012. [Abstract] [Full Text]

				Y. Tanoue, S. Morita, Y. Ochiai, M. Hisahara, M. Masuda, Y. Kawachi, R. Tominaga, and H. Yasui INHIBITION OF LIPID PEROXIDATION WITH THE LAZAROID U74500A ATTENUATES ISCHEMIA-REPERFUSION INJURY IN A CANINE ORTHOTOPIC HEART TRANSPLANTATION MODEL J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1017 - 1026. [Abstract] [Full Text]

				J. Lee, D. C. Drinkwater Jr., H. Laks, A. Chong, A. Blitz, M. A. Chen, L. J. Ignarro, and P. Chang PRESERVATION OF ENDOTHELIUM-DEPENDENT VASODILATION WITH LOW-POTASSIUM UNIVERSITY OF WISCONSIN SOLUTION J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 103 - 110. [Abstract] [Full Text]

				M. Carrier, T. K. Leung, B. C. Solymoss, R. Cartier, Y. Leclerc, and L. C. Pelletier Clinical Trial of Retrograde Warm Blood Reperfusion Versus Standard Cold Topical Irrigation of Transplanted Hearts Ann. Thorac. Surg., May 1, 1996; 61(5): 1310 - 1314. [Abstract] [Full Text]

				F. L. Rosenfeldt, R. A. J. Conyers, P. Jablonski, L. Langley, S. M. Richards, G. Self, and V. Marshall Comparison of UW Solution and St. Thomas' Solution in the Rat: Importance of Potassium Concentration Ann. Thorac. Surg., February 1, 1996; 61(2): 576 - 584. [Abstract] [Full Text]

				J. P. Slater, M. M.R. Amirhamzeh, O. J. Yano, A. S. Shah, J. P. Starr, R. J. Kaplon, W. Burfeind, P. Pepino, R. E. Michler, E. A. Rose, et al. Discriminating Between Preservation and Reperfusion Injury in Human Cardiac Allografts Using Heart Weight and Left Ventricular Mass Circulation, November 1, 1995; 92(9): 223 - 227. [Abstract] [Full Text]

				K. Ono, N. Gondo, M. Arita, H. A. Fozzard, T. Hadama, and Y. Uchida University of Wisconsin Solution Preserves Myocardial Calcium Current Response to Isoproterenol in Isolated Canine Ventricular Myocytes Circulation, November 1, 1995; 92(9): 452 - 457. [Abstract] [Full Text]

				D. C. Drinkwater Jr., E. T. Ziv, H. Laks, J. R. Lee, S. Bhuta, E. Rudis, and P. Chang Extracellular and standard University of Wisconsin solutions provide equivalent preservation of myocardial function J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 738 - 745. [Abstract] [Full Text]

				S. E. Fremes, J. Zhang, R. D. Furukawa, D. A. G. Mickle, and R. D. Weisel ADENOSINE PRETREATMENT FOR PROLONGED CARDIAC STORAGEAn evaluation with St. Thomas' Hospital and University of Wisconsin solutions J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 293 - 301. [Abstract] [Full Text]

				S. E. Fremes, R. D. Furukawa, J. Zhang, R.-K. Li, L. C. Tumiati, R. D. Weisel, and D. A. G. Mickle Cardiac Storage With University of Wisconsin Solution and a Nucleoside-Transport Blocker Ann. Thorac. Surg., May 1, 1995; 59(5): 1127 - 1133. [Abstract] [Full Text]

				J. C. Stringham, K. L. Paulsen, J. H. Southard, R. M. Mentzer Jr., and F. O. Belzer Prolonging myocardial preservation with a modified University of Wisconsin solution containing 2,3-butanedione monoxime and calcium J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 764 - 775. [Abstract] [Full Text]

				J. M. Pearl, H. Laks, D. C. Drinkwater, T. J. Sorensen, P. Chang, A. S. Aharon, R. E. Byrns, and L. J. Ignarro Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 257 - 264. [Abstract] [Full Text]